Aurubis (ETR:NDA)‘s stock had its “neutral” rating restated by investment analysts at DZ Bank in a research report issued to clients and investors on Tuesday.
Several other equities research analysts also recently weighed in on the company. Hauck & Aufhaeuser set a €88.00 ($108.64) price target on Aurubis and gave the stock a “buy” rating in a report on Thursday, January 4th. Commerzbank set a €65.00 ($80.25) price target on Aurubis and gave the stock a “sell” rating in a report on Wednesday, November 15th. Baader Bank set a €74.00 ($91.36) price target on Aurubis and gave the stock a “neutral” rating in a report on Thursday, December 7th. Warburg Research set a €90.00 ($111.11) price target on Aurubis and gave the stock a “buy” rating in a report on Monday, December 18th. Finally, Credit Suisse Group set a €72.16 ($89.09) price target on Aurubis and gave the stock a “neutral” rating in a report on Monday, January 1st. Six equities research analysts have rated the stock with a sell rating, six have given a hold rating and four have given a buy rating to the company. Aurubis presently has an average rating of “Hold” and a consensus price target of €73.48 ($90.71).
Shares of Aurubis (ETR NDA) traded down €5.16 ($6.37) during midday trading on Tuesday, hitting €75.14 ($92.77). The company had a trading volume of 460,612 shares, compared to its average volume of 221,704. Aurubis has a 52-week low of €51.54 ($63.63) and a 52-week high of €86.80 ($107.16). The firm has a market capitalization of $3,650.00 and a P/E ratio of 9.62.
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.